LSM5

Across TCGA pan-cancer cohorts, LSM5 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LSM5 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LSM5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LSM5 expression acts as an unfavorable survival marker.

COAD are the cancer types where LSM5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.168	0.806	.002	15	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

LSM5–COAD (OS)

Open the COAD breakdown →